E
Molecular Partners AG MOLN
$4.03 $0.122.97% NASDAQ
Recommendation
Prev Close
$3.63
Volume
858
Avg Vol (90D)
2,476
Market Cap
$135.00M
Dividend & Yield
--
52-Week Range
$3.36 - $6.24
P/E (TTM)
--
EPS (TTM)
-$2.09
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Molecular Partners AG (MOLN, $4.09) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 3, 2025
11/4/2025 - Tickeron - Stocks
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 ...
11/3/2025 - GuruFocus
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual ...
11/3/2025 - GuruFocus
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
11/3/2025 - Globe Newswire
Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025
11/3/2025 - Globe Newswire
Molecular Partners AG (MOLN, $3.63) price exceeded its 50-day Moving Average on October 31, 2025
11/1/2025 - Tickeron - Stocks
Molecular Partners (NASDAQ:MOLN) Announces Earnings Results
11/1/2025 - MarketBeat
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting ...
10/30/2025 - GuruFocus
Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025
10/30/2025 - Globe Newswire
Molecular Partners AG (MOLN, $3.56) Stochastic Oscillator left the oversold zone on October 23, 2025
10/24/2025 - Tickeron - Stocks
Molecular Partners (MOLN) Expected to Announce Quarterly Earnings on Thursday
10/23/2025 - MarketBeat
Molecular Partners AG (MOLN, $3.7) price exceeded its 50-day Moving Average on October 21, 2025
10/22/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.7) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 21, 2025
10/22/2025 - Tickeron - Stocks
Molecular Partners (NASDAQ:MOLN) Earns Sell (D-) Rating from Weiss Ratings
10/14/2025 - MarketBeat
Molecular Partners (NASDAQ:MOLN) Stock Price Down 2.1% - Here's What Happened
10/11/2025 - MarketBeat
Molecular Partners AG (MOLN, $3.68) price exceeded its 50-day Moving Average on September 29, 2025
9/30/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 26, 2025
9/27/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.68) Stochastic Oscillator left the oversold zone on September 24, 2025
9/25/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.67) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 22, 2025
9/23/2025 - Tickeron - Technical Analysis
Molecular Partners AG (MOLN, $3.67) price exceeded its 50-day Moving Average on September 22, 2025
9/23/2025 - Tickeron - Technical Analysis
Molecular Partners AG (MOLN, $3.77) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 19, 2025
9/20/2025 - Tickeron - Stocks
Molecular Partners (NASDAQ:MOLN) Shares Up 1.5% - What's Next?
9/19/2025 - MarketBeat
Molecular Partners AG (MOLN, $3.64) price exceeded its 50-day Moving Average on September 16, 2025
9/17/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.64) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 16, 2025
9/17/2025 - Tickeron - Stocks
Molecular Partners AG (MOLN, $3.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 10, 2025
9/11/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$787.30K
EBITDA (TTM)
-$67.24M
EBIT (TTM)
-$69.49M
Net Income (TTM)
-$75.14M
Balance Sheet
Total Assets (Q)
$156.24M
Total Debt (Q)
$2.31M
Total Liabilities (Q)
$22.12M
Book Value Per Share (Q)
$3.59
Cash Flow
Cash from Operations (TTM)
-$65.26M
Cash from Investing (TTM)
$68.36M
Cash from Financing (TTM)
$16.45M
Net Change in Cash (TTM)
$18.13M
Filings
Filing Date
Monday, August 25, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
1.94
7-Day Total Return
13.10%
30-Day Total Return
9.71%
60-Day Total Return
9.86%
90-Day Total Return
12.46%
Year to Date Total Return
-17.33%
1-Year Total Return
-34.21%
2-Year Total Return
10.31%
3-Year Total Return
-34.64%
5-Year Total Return
--
52-week Low
Apr 29, 2025 - $3.36
52-week High
Nov 01, 2024 - $6.24
Valuation
Market Cap
$135.00M - Micro Cap
Enterprise Value
$6.78M
Price/Sales (TTM)
173.03
Price/Book (Q)
1.01
Dividends and Shares
Shares Outstanding
37.39
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.molecularpartners.com
Phone Number
41 44 755 77 00
Address
Wagistrasse 14
Schlieren, 8952
Country
Switzerland
Year Founded
2004
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its... more
NASDAQ 11/05/2025 3:59PM Eastern Quotes delayed